Abstract
Combined related haploidentical-unrelated umbilical cord blood stem cell transplants (RH-UUCB SCT) is a new approach for treatment of patients with hematological malignancies who lack HLA matched donors.. Although additional cells from the haploidentical donor reduce complications associated with late engraftment in UUCB SCT, patients with RH-UUCB SCT are challenged with a higher degree of HLA disparities and potential complication associated with them.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
